Results 61 to 70 of about 1,964,079 (337)

Effects of Mindfulness-Based Cancer Recovery training on anxiety, depression, post-traumatic stress disorder, and cancer-related fatigue in breast neoplasm patients undergoing chemotherapy

open access: yesMedicine
Rationale: Mindfulness-Based Cancer Recovery (MBCR) program is a group course training for cancer patients that combines cancer knowledge and psychological knowledge, emphasizing focusing on the psychosomatic symptoms of cancer patients.
Fan Xu   +3 more
semanticscholar   +1 more source

Exposure to di-2-ethylhexyl phthalate and breast neoplasm incidence: A cohort study.

open access: yesScience of the Total Environment
BACKGROUND Phthalates are ubiquitous environmental endocrine disruptors. As the predominant phthalate, di-2-ethylhexyl phthalate (DEHP) has been considered possibly carcinogenic to humans but large-scale longitudinal evidence is needed to further clarify
Lijuan Tang   +9 more
semanticscholar   +1 more source

Clinicopathological study of breast diseases: A hospital-based study

open access: yesJournal of Pathology of Nepal, 2019
Background: Breast diseases are more common in women than men. Breasts undergo perpetual physical and physiological transition from puberty till death, which are related to menstruation, pregnancy, and menopause. The aim of this was to classify different
Ramesh Chavan, Anil Prasad
doaj   +1 more source

Papillary Neoplasms of the Breast: A Review

open access: yesArchives of Pathology & Laboratory Medicine, 2009
Abstract Context. —Interpretation of papillary lesions of the breast remains a challenging task because of the wide morphologic spectrum encountered in the benign, atypical, and malignant subtypes. Data on clinical significance and outcome of papillary lesions, with superimposed atypia or areas
Shir-Hwa, Ueng   +2 more
openaire   +2 more sources

Breast Papilloma without Atypia and Risk of Breast Carcinoma

open access: yes, 2014
The incidence of asymptomatic papilloma has increased with the rising popularity of core needle biopsy for breast lesions. In this study, the risk of benign papilloma without atypia for subsequent breast carcinoma during follow-up was evaluated.
문희정   +3 more
core   +1 more source

Rising global burden of breast cancer: the case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: a review

open access: yesWorld Journal of Surgical Oncology, 2018
BackgroundDespite mortality from breast cancer in Africa being higher than in high income countries, breast cancer has not been extensively studied in the region.
S. Azubuike   +3 more
semanticscholar   +1 more source

Histological and molecular classification of breast cancer: what do we know?

open access: yes, 2020
Breast cancer is the neoplasm most diagnosed malignancy and the leading cause of mortality among women on a global scale. A profound increase in the understanding and clinical management of breast cancer has occurred over the past two decades, which has ...
Renan Gomes do Nascimento   +1 more
semanticscholar   +1 more source

Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-Analysis

open access: yesJournal of Clinical Endocrinology and Metabolism, 2020
Background: Risk of cancer is a major concern in the development of drugs for the treatment of obesity and diabetes. In randomized controlled trials (RCTs) of the liraglutide development program, a glucagon-like peptide-1 receptor agonist (GLP-1RA ...
G. Piccoli   +9 more
semanticscholar   +1 more source

Phosphatidylinositol 4‐kinase as a target of pathogens—friend or foe?

open access: yesFEBS Letters, EarlyView.
This graphical summary illustrates the roles of phosphatidylinositol 4‐kinases (PI4Ks). PI4Ks regulate key cellular processes and can be hijacked by pathogens, such as viruses, bacteria and parasites, to support their intracellular replication. Their dual role as essential host enzymes and pathogen cofactors makes them promising drug targets.
Ana C. Mendes   +3 more
wiley   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy